SpringWorks' non-cancerous tumor drug to be priced at $29,000 per month in US
Reuters· 2 日前SpringWorks Therapeutics' (SWTX.O) drug for treating adult patients with a type of rare non- ...
US FDA approves SpringWorks Therapeutics' non-cancerous tumor treatment
Reuters· 3 日前The U.S. health regulator on Monday approved SpringWorks Therapeutics' (SWTX.O) drug for treating adult patients with desmoid ...